Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic

To see complete record on, please visit this link

Id: NCT04769297

Organisation Name: Limbic Medical

Overal Status: Unknown status

Start Date: April 15, 2020

Last Update: February 24, 2021

Lead Sponsor: Limbic Medical

Brief Summary: A retrospective chart review of an open-label trial of low-dose ketamine administered to front-line Healthcare workers who were identified as experiencing acute stress disorder due to the COVID-19 Pandemic.

  • Acute Stress Disorder

Total execution time in seconds: 0.19763803482056